BSO logo
  • Sitemap
  • Accessibility
  • Print
  • small text
  • medium text
  • large text
  • Home
  • About BSO
    • BSO Board
    • BSO Locations
    • BSO Service Catalogue
    • Corporate Information
  • Services
    • PaLS Homepage
    • Bursary Administration Unit
    • COMPASS
    • Counter Fraud and Probity Services
    • Customer Relations/ Service Improvement
    • Directorate of Legal Services
    • Equality and Human Rights
    • Family Practitioner Services
    • Finance
    • Honest Broker Service
    • Human Resources & Corporate Services
    • Infected Blood Payment Scheme for NI
    • Information Technology Services
    • Internal Audit
    • NI HSC Interpreting Service
    • ORECNI
    • Payroll
    • Small Business Research Initiative (SBRI)
  • Public Information
    • Latest News
    • General Enquiries
    • Access to Information
    • Publication Scheme
    • GDPR
    • Freedom of Information
    • Environmental Information Regulations
    • Statistical Information
    • Register of Meetings with Pharmaceutical & Medical Suppliers
    • Complaints
    • Cookies Policy
    • BSO Policies and Procedures
    • Regional Recruitment & Selection Framework 2018
  • Working for Us
    • Working For Us
  • Contact Us
    • Fraud Reporting
  • Home
  • Services
  • Family Practitioner Services
  • FPS Pharmaceutical Services
  • HSCB Services and Guidance
  • Harm Reduction Services

Harm Reduction Services

1. Opioid Substitution Treatment Service

  • OST Service Specification
  • Service User and Provider Agreement (Generic)
  • Belfast HSC Trust "Substitute Prescribing Agreement"
  • Oromucosal Buprenorphine : Espranor®
  • References
  1. Opioid Substitution Treatment : Northern Ireland Supplementary Guidance for Community Pharmacists 2019
  2. Opioid Substitution Treatment : Cover letter issued with Northern Ireland Supplementary Guidance for Community Pharmacists 2019 (July 2019)
  3. Drug Misuse and Dependence : UK Guidelines on Clinical Management 2017

https://www.gov.uk/government/publications/drug-misuse-and-dependence-uk-guidelines-on-clinical-management

 

 

2. Needle and Syringe Exchange Service

  • NSES Service Specification (2018)
  • Guidance for Community Pharmacy Needle Exchange (2017)
  • List of Community Pharmacy Providers (2020)
  • Low Threshold Services (2017)
  • Needle and Syringe Provision : Self Select Order Form (PHA,2020)
  • Needle and Syringe Provision : NI Guide to Needle Exchange Pack Contents
  • References
  1. Needle and Syringe Exchange Scheme Leaflet
  2. Annual Report of the Needle & Syringe Exchange Scheme

 

 

3.Naloxone

  • References
  1. "Widening the availability of Naloxone" Guidance 2017

   https://www.gov.uk/government/publications/widening-the-availability-of-naloxone/widening-the-availability-of-naloxone

       2.  Take Home Naloxone

http://www.publichealth.hscni.net/publications/take-home-naloxone

Contents

  • Oromucosal Buprenorphine : Espranor


  • © Copyright
  • Disclaimer
  • Cookies
  • Privacy Notice
  • Freedom of Information